Lyell Immunopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Aug 23 | SellUS$132,286 | Richard Klausner | Individual | 58,020 | US$2.28 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 33,041 | 0.013% |
Individual Insiders | 8,955,104 | 3.52% |
Public Companies | 30,253,189 | 11.9% |
General Public | 31,288,533 | 12.3% |
VC/PE Firms | 51,506,685 | 20.3% |
Institutions | 132,059,759 | 52% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
36,412,716 | US$87.8m | 0% | 6.32% | |||
30,253,189 | US$72.9m | 0% | no data | |||
20,162,332 | US$48.6m | 0% | 40.36% | |||
15,093,969 | US$36.4m | 0% | 16.3% | |||
15,093,969 | US$36.4m | 0% | 1.05% | |||
14,302,220 | US$34.5m | 6.57% | no data | |||
13,604,027 | US$32.8m | -19.6% | no data | |||
8,325,000 | US$20.1m | -5.23% | 5.55% | |||
8,180,678 | US$19.7m | 0% | 39.15% | |||
6,638,883 | US$16.0m | -0.71% | no data | |||
5,865,125 | US$14.1m | 0% | 1.2% | |||
4,685,614 | US$11.3m | 0% | no data | |||
3,937,350 | US$9.5m | 7.68% | no data | |||
3,898,714 | US$9.4m | 0% | no data | |||
3,539,086 | US$8.5m | -48% | no data | |||
3,477,228 | US$8.4m | 365% | 0.01% | |||
3,045,997 | US$7.3m | 0% | 0.52% | |||
2,788,723 | US$6.7m | -2.06% | no data | |||
1,740,569 | US$4.2m | 0% | 0.79% | |||
1,596,845 | US$3.8m | 124% | no data | |||
1,475,509 | US$3.6m | -0.52% | no data | |||
1,354,678 | US$3.3m | -0.62% | no data | |||
1,266,863 | US$3.1m | 0% | no data | |||
916,232 | US$2.2m | 0% | no data | |||
899,017 | US$2.2m | 360% | no data |